Sunday, June 11, 2017 9:12:57 PM
Hmmmm....quite a coincidence or not....but this mention of "Peregrine" below was funded by Sandia
Peregrine RNA-Seq library
Peregrine
A rapid and unbiased method to produce strand-specific RNA-Seq libraries from small quantities of starting material
Stanley A. Langevin, Zachary W. Bent, [...], and Steven S. Branda
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710357/
Very interesting puzzle piece here....brings us back to Ayer Capital Management (Dr Jay Venkatesan and Pieter Boulhower ..)
July 2015 Dr Venkatesan joins Alpine
http://www.businesswire.com/news/home/20150713005408/en/Dr.-Jay-Venkatesan-Joins-Alpine-BioVentures-Managing#.VaOo8SizzDc
http://www.alpinebioventures.com/team/
Now...Alpine Biosciences acquired by Cascadian Therapeutics in August 2014 ...but read below...they licensed tech from Sandia National Labs!! ....and Sandia just had the Peregrine RNA sequence library!
We founded Alpine Biosciences in 2012 to develop "protocells", a unique nanoparticle platform technology licensed from University of Mexico and Sandia National Labs....
http://www.alpinebioventures.com/portfolio/
.....Peregrine what is it you have not been able to tell us and these are solid puzzle pieces. You telling me Dr Venkatesan with Ayer Capital mgmt....sells or forced to sell PPHM and now lands where Alpine with ties to Sandia Nation Labs that were researching Peregrine RNA proteins....??
